Related Experiment Video
Updated: May 19, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
FDG PET and FDG PET/CT in patients with gastrointestinal stromal tumours
Philipp Malle1, Manfred Sorschag, Hans-Jürgen Gallowitsch
1Department of Nuclear Medicine and Endocrinology, PET-CT Center Klagenfurt, Klinikum Klagenfurt am Wörthersee, Feschnigstraße 11, 9020 Klagenfurt, Austria. philipp.malle@kabeg.at
Abstract:
Gastrointestinal stromal tumours (GISTs) are fairly rare neoplasms, constituting less than 3 % of all gastrointestinal malignancies. The integration of molecularly targeted treatment regimes (i.e., tyrosine kinase inhibitors) in clinical oncology has revolutionized the management of patients with irresectable GISTs or metastatic disease. Malignant GISTs usually display increased glucose metabolism and therefore (18)F-fluorodeoxyglucose (FDG) uptake within the scope of positron emission tomography (PET) scans. Nowadays, dual-modality FDG PET/CT (computed tomography) imaging is of considerable value in diagnostic work-up of patients with GISTs acquiring functional and anatomic information simultaneously. The following article sheds light on the impact of FDG PET and combined FDG PET/CT imaging in initial disease evaluation, detection of tumour recurrence and the early assessment of treatment response to molecularly targeted agents such as imatinib mesylate or sunitinib maleate.
Insights
Positron emission tomography (PET) scans using (18)F-fluorodeoxyglucose (FDG) aid in evaluating gastrointestinal stromal tumours (GISTs). FDG PET/CT imaging is valuable for diagnosis, recurrence detection, and assessing treatment response in GIST patients.
Area of Science:
- Oncology
- Nuclear Medicine
- Radiology
Background:
- Gastrointestinal stromal tumours (GISTs) are rare malignancies, accounting for <3% of all GISTs.
- Molecularly targeted therapies, like tyrosine kinase inhibitors, have transformed GIST management.
- Malignant GISTs exhibit heightened glucose metabolism, leading to increased (18)F-fluorodeoxyglucose (FDG) uptake.
Purpose of the Study:
- To elucidate the role of FDG PET and FDG PET/CT in GIST diagnosis and management.
- To highlight the utility of dual-modality imaging for simultaneous functional and anatomical information.
- To review the impact of FDG PET/CT in initial staging, recurrence detection, and treatment response assessment.
Main Methods:
- Utilizing (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) scans.
- Employing dual-modality FDG PET/CT imaging for integrated assessment.
- Reviewing diagnostic and therapeutic applications in GIST patient management.
Main Results:
- FDG PET/CT provides simultaneous functional and anatomical data crucial for GIST evaluation.
- The imaging modality is valuable for initial disease assessment and detecting tumour recurrence.
- FDG PET/CT enables early assessment of treatment response to targeted therapies like imatinib and sunitinib.
Conclusions:
- FDG PET and FDG PET/CT imaging are integral tools in the comprehensive management of GISTs.
- These imaging techniques offer significant value in diagnosis, monitoring recurrence, and evaluating therapeutic efficacy.
- Dual-modality imaging enhances diagnostic accuracy and treatment monitoring for patients with GISTs.
Related Concept Videos
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
